Microvascular disease anywhere in the body may be linked to higher risk of leg amputations

Dallas, Texas - Microvascular disease is independently associated with a higher risk of leg amputation compared to people without the disease, according to new research in the American Heart Association’s journal Circulation.

FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections

Washington, DC - The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

Executive Order on Advancing American Kidney Health

Washington, DC - By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows:

NIH publishes the largest genomic study on type 2 diabetes in sub-Saharan African populations

Washington, DC - National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan Africans, with data from more than 5,000 individuals from Nigeria, Ghana and Kenya. Researchers confirmed known genomic variants and identified a novel gene ZRANB3, which may influence susceptibility to the disease in sub-Saharan African populations.

FDA seeks to advance safe and effective prostate tissue ablation devices

Washington, DC - Today, the FDA issued a draft guidance to provide recommendations for device manufacturers regarding the clinical testing that must be conducted in accordance with special controls for high intensity ultrasound systems for prostate tissue ablation devices regulated under the agency’s 510(k) premarket notification program.